- Active not recruitingPHASE3
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older
This study looks at the long-term safety and how well a medicine called ELX/TEZ/IVA works for people with cystic fibrosis, aged 12 months and older. It continues to check on participants who have already been taking the medicine in a previous study.
For: Cystic FibrosisAustralia · Canada · Denmark - Active not recruitingPHASE1, PHASE2
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
This study is testing a new medicine, VX-522, for adults with cystic fibrosis (CF) whose current treatments aren't effective. It aims to see if the medicine is safe, well-tolerated, and helpful for improving their condition. This is an important step in finding new ways to manage CF.
For: Cystic FibrosisUnited States · Australia · Belgium - Active not recruitingPHASE3
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
This study looks at a new treatment called ELX/TEZ/IVA for cystic fibrosis, specifically for people who don't have a common gene change (F508del). It's checking if the treatment is safe and works well over a long time.
For: Cystic FibrosisAustria · Belgium · Canada